AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
22.47
-0.91 (-3.89%)
At close: Jun 27, 2025, 4:00 PM
22.08
-0.39 (-1.74%)
After-hours: Jun 27, 2025, 6:03 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for AnaptysBio stock ranges from a low of $20 to a high of $90. The average analyst price target of $44.25 forecasts a 96.93% increase in the stock price over the next year.
Price Target: $44.25 (+96.93%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 2 |
| Buy | 5 | 6 | 5 | 5 | 5 | 5 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $22 → $38 | Hold → Strong Buy | Upgrades | $22 → $38 | +69.11% | Jun 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $54 → $90 | Strong Buy | Maintains | $54 → $90 | +300.53% | May 28, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $52 → $54 | Strong Buy | Maintains | $52 → $54 | +140.32% | May 6, 2025 |
| Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +78.02% | May 1, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $36 → $42 | Buy | Maintains | $36 → $42 | +86.92% | Mar 5, 2025 |
Financial Forecast
Revenue This Year
66.99M
from 91.28M
Decreased by -26.61%
Revenue Next Year
83.32M
from 66.99M
Increased by 24.39%
EPS This Year
-5.41
from -5.12
EPS Next Year
-5.06
from -5.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 149.7M | 216.3M | 155.9M | ||
| Avg | 67.0M | 83.3M | 82.3M | ||
| Low | 27.2M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 64.0% | 222.9% | 87.0% | ||
| Avg | -26.6% | 24.4% | -1.3% | ||
| Low | -70.2% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.09 | -1.56 | -3.02 | ||
| Avg | -5.41 | -5.06 | -5.58 | ||
| Low | -6.88 | -6.76 | -9.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.